CMG
58
-5
KHC
15
2
FOXA
63
-3
STI
44
32
MLM
35
-2
HOG
26
-3
MMC
48
-2
NUE
40
-3
DTE
52
-2
NI
67
-3
ITW
45
-3
PPL
44
-3
MMM
35
-5
FRT
34
-5
MCD
55
-2
PG
43
-3
PEG
55
-2
GME
68
-4
DGX
25
-3
CRM
64
-3
CMG
58
-5
KHC
15
2
FOXA
63
-3
STI
44
32
MLM
35
-2
HOG
26
-3
MMC
48
-2
NUE
40
-3
DTE
52
-2
NI
67
-3
ITW
45
-3
PPL
44
-3
MMM
35
-5
FRT
34
-5
MCD
55
-2
PG
43
-3
PEG
55
-2
GME
68
-4
DGX
25
-3
CRM
64
-3
Financhill
Back

Cue Biopharma 10K Form

Sell
40

CUE
Cue Biopharma

Last Price:
$1.07
Seasonality Move:
-5.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CUE News And Ratings

See the #1 stock for the next 7 days that we like better than CUE

CUE Financial Statistics

Sales & Book Value

Annual Sales: $5.5M
Cash Flow: $-7.5M
Price / Cash Flow: 0
Annual Sales: $0.42
Price / Book: 2.6

Profitability

EPS (TTM): -0.91000
Net Income (TTM): $-44.6M
Gross Margin: --
Return on Equity: -142.28%
Return on Assets: -82.16%

Cue Biopharma Earnings Forecast

Key Cue Biopharma Financial Ratios

  • The Research & Development expenses have been 743.21% of Revenue.
  • The Interest Expense is -2.45% of Operating Income.
  • The Net Earning history of CUE is -924.10% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Cue Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CUE
CUSIP: 22978P
Website: cuebiopharma.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 2.22
Quick Ratio: 2.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CUE Technical Analysis vs Fundamental Analysis

Sell
40
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy or a Sell?

  • Cue Biopharma stock is rated a Sell
    The current Cue Biopharma [CUE] share price is $1.04. The Score for CUE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.